Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MicroRNA Expression Analysis of Advanced Colorectal Cancer Reveals a microRNA Signature with Prognostic and Predictive Value

ABSTRACT: We performed a prospective cohort study in patients with advanced CRC to identify a miRNA signature that could predict the benefit of receiving first-line chemotherapy for these patients.

ORGANISM(S): Homo sapiens

PROVIDER: GSE108153 | GEO | 2017/12/16

SECONDARY ACCESSION(S): PRJNA422598

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

The prognostic and predictive value of a three-microRNA-based classifier in NSCLC

Project description:MicroRNA expression profiles were sucessfully contructed in 397 patients with NSCLC and 151 corresponding adjacent noncancerous tissues using a custom microarray containing probes for 1888 miRNAs and an outcome prediction of miRNA signature was successfully identified for predicting prognosis in NSCLC.

2017-08-22 | GSE53882 | GEO

Predictive and prognostic value of prognostic nutritional index for locally advanced breast cancer.

Project description: Not available

| S-EPMC6989918 | biostudies-literature

Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer

Project description:Background: The JBR.10 trial demonstrated significant survival benefit from adjuvant cisplatin/vinorelbine (ACT) in stage IB-II NSCLC (HR 0.69, p=0.04), but stage IB patients did not derive significant benefit (HR: 0.94, p= 0.79). We hypothesized that expression profiling could identify stage-independent subgroups of patients who might benefit from adjuvant chemotherapy. Methods: Gene expression profiling was conducted on mRNA isolated from frozen JBR.10 tumor samples (either from patients under observation [OBS], or treated with ACT). The minimum gene set that selected for the greatest separation of good and poor prognosis patient subgroups in OBS patients was identified and this gene signature was used to classify patients into high and low risk for death after surgery, and predict ACT effect. The prognostic gene signature was additionally tested on ACT patients and publicly available microarray datasets. Results: A 15-gene signature separated OBS patients into equal high and low risk subgroups with significantly different prognoses (HR 15.02, 95% CI 5.12-44.04, p=0.0001). The signature was prognostic in both stage IB and II. It was also predictive of improved survival following ACT treatment in high-risk patients (HR 0.33, 95% CI 0.17-0.63, p=0.0005), but not in low risk patients (HR 3.67, 95% CI 1.22-11.06, p=0.0133; interaction p=0.0001). The prognostic effect of the signature was validated in two independent gene expression datasets of 169 stage I-II adenocarcinoma and 106 squamous cell carcinoma patients. Conclusions: This microarray-based 15-gene prognostic expression signature is stage and histology independent and may select early stage NSCLC patients who are most likely to benefit from adjuvant chemotherapy with cisplatin/vinorelbine. Keywords: Expression profiling by microarray; prognosis prediction 90 samples

2010-09-09 | E-GEOD-14814 | biostudies-arrayexpress

Serum IGF1 is a new prognostic marker for resistance to targeted therapies and a predictive marker for anti-IGF1R therapy in melanoma

Project description:In a prospective clinical study, we show that increased serum IGF1 levels in a patient may be a predictive marker of melanoma escape to therapies targeting MAPK pathway (BRAFi/MEKi). In addition, our in vitro and in vivo studies suggest that the response of targeted therapies-resistant melanoma cells to IGF1R inhibitor appears to correlate with the level of IGF1 secretion. Overall, our results suggest that monitoring serum IGF1 levels would individually identify melanoma patients who escape BRAFi/MEKi treatment and may benefit from a combination of targeted therapies and IGF1 signaling inhibition to overcome resistance.

2023-10-30 | GSE239284 | GEO

The prognostic and predictive value of a five-microRNA-based classifier in breast cancer

Project description:microRNA profiling of breast cancer specimens vs noncancerous breast tissues

2018-01-01 | GSE57897 | GEO

MicroRNA Expression Analysis of Advanced Colorectal Cancer Reveals a microRNA Signature with Prognostic and Predictive Value

Project description:MicroRNA Expression Analysis of Advanced Colorectal Cancer Reveals a microRNA Signature with Prognostic and Predictive Value

| PRJNA422598 | ENA

Prognostic and predictive value of a microRNA signature in adults with T-cell lymphoblastic lymphoma

Project description:microRNA profiling of T-cell lymphoblastic lymphoma vs fetal thymus

2018-04-30 | GSE113749 | GEO

Predictive Value of Proteomic Markers for Advanced Rectal Cancer with Neoadjuvant Chemoradiotherapy

Project description:Thirteen paired pre- and post-nCRT sera from rectal cancer patients were analyzed by isobaric tags for relative and absolute quantitation (iTRAQ) method. Twenty-five proteins were selected for validation by parallel reaction monitoring (PRM) in ninety-one patients.

2022-03-08 | PXD032117 | iProX

Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer

Project description:This study investigates the predictive and prognostic values of inflammatory markers and microRNA in stage IV colorectal cancer. The expression of inflammatory markers and microRNA in plasma will be correlated with tumor location, with dietary patterns and with survival during treatment.

| 2320890 | ecrin-mdr-crc

The prognostic and predictive value of a six-microRNA-based classifier in stage II colon cancer

Project description:microRNA profiling of colon tumor tissues vs adjacent normal tissues

2013-11-29 | GSE49246 | GEO